OKYO Pharma Ltd (NASDAQ:OKYO) announced that Panetta Partners Limited, an entity in which the company’s chairman Gabriele Cerrone has a beneficial interest, has purchased 80,000 shares at US$1.15 per share.
This brings Cerrone’s stake in the company to 9,801,570 shares or 28.97% of issued share capital.
OKYO Pharma is is a clinical stage biopharmaceutical company developing innovative therapies for the treatment of dry eye disease and neuropathic corneal pain.